Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $127.20M in the quarter ending March 31, 2026, with 55.63% growth. This brings the company's revenue in the last twelve months to $536.20M, up 96.03% year-over-year. In the year 2025, Travere Therapeutics had annual revenue of $490.73M with 110.45% growth.

• Revenue (ttm): $536.20M
• Revenue Growth: +96.03%
• P/S Ratio: 7.71
• Revenue / Employee: $1,078,863
• Employees: 497
• Market Cap: 4.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	490.73M	257.55M	110.45%
Dec 31, 2024	233.18M	87.94M	60.55%
Dec 31, 2023	145.24M	35.78M	32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.49M	-33.52%
Dec 31, 2020	198.32M	22.98M	13.11%
Dec 31, 2019	175.34M	11.09M	6.75%
Dec 31, 2018	164.25M	9.31M	6.01%
Dec 31, 2017	154.94M	21.35M	15.98%
Dec 31, 2016	133.59M	33.70M	33.74%
Dec 31, 2015	99.89M	71.69M	254.19%
Dec 31, 2014	28.20M	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-

Data Source: Fiscal.ai Last updated: May 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error